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Cell fusion occurs in many cellular processes and viral infections. We developed a new, quantitative cell fusion assay based on the
tetracycline-controlled transactivator (tTA)-induced expression of a luciferase reporter gene. The assay is objective, sensitive, linear over 2–3
orders of magnitude, amenable to microtiter-plate format, and generalizable to study fusion mediated by a variety of genes. Applied to HIV
and MLV, cell fusion paralleled virus entry in terms of co-receptor requirements, need for post-translational processing of envelope, and
complementation of SU mutations by soluble receptor-binding domain. However, biochemically measured fusion did not correlate with
syncytia detected by standard light microscopy. When the assay indicated cell fusion occurred but overt syncytia were not observed, confocal
microscopy using fluorescent protein markers showed that fusion was limited mainly to pairs of cells. Such nonprogressive cell fusion
suggests that post-translational processing of envelope may be altered in heterokaryons co-expressing envelope and receptor.
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Cell fusion is important in many developmental pro-
cesses such as formation of placenta, muscle, and bone
(Blobel et al., 1992; Mi et al., 2000; Vignery, 2000;
Yagami-Hiromasa et al., 1995), in inflammatory conditions
(Anderson, 2000), and in viral infections. In most of these
cases, the fusing cells form multinucleate giant cells, i.e.,
syncytia, easily detectable by light microscopy. However,
cell fusion can be subtler, involving only two cells, yet still
have enormous consequences, as in fertilization or forma-
tion of somatic cells hybrids. Cell fusion is important in
research and bioengineering applications such as somatic0042-6822/$ - see front matter. Published by Elsevier Inc.
doi:10.1016/j.virol.2004.02.032
* Corresponding author. Laboratory of Molecular Microbiology,
National Institute of Allergy and Infectious Disease, National Institutes of
Health, Building 4, Room 336, 4 Center Drive, MSC 0460, Bethesda, MD
20892-0460. Fax: +1-301-402-0226.
E-mail addresses: wou@niaid.nih.gov (W. Ou), jsilver@nih.gov
(J. Silver).
1 Current address: Department of Vascular Biology, American Red
Cross, Holland Lab, Rockville, MD 20855, USA.cell genetics and monoclonal antibody production, and
recently has been found to be responsible for some cases
of stem cell transdifferentiation (Terada et al., 2002; Ying
et al., 2002).
Cell fusion mediated by virus envelope genes provides a
model to study the process by which enveloped viruses
enter cells. Virus-induced cell fusion may also be responsi-
ble for some forms of virus cytopathicity in vivo. Virus-
induced syncytium formation has been used to quantify viral
infection (Rowe et al., 1970), although the ability to form
syncytia is often restricted to particular cell types or virus
strains. Little is known about why some cells readily form
syncytia while others do not, although they may be equally
susceptible to virus infection, or why syncytium formation
can be associated with point mutation in the receptor
binding domain of viral envelope genes (Chung et al.,
1999; Watkins et al., 1997), or shortening the cytoplasmic
tail of viral envelope TM genes (Rein et al., 1994; Spies and
Compans, 1994; Zingler and Littman, 1993). As a step
toward understanding the relationship between virus-medi-
ated cell fusion and syncytium formation, we developed a
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ined its relationship to syncytium formation detected by
light microscopy.
Several biochemical fusion assays have already been
developed using indicator genes whose transcription is
activated by cell fusion. Some assays are based on
transcriptional transactivation by HIV-1 tat of an indicator
gene under the control of the HIV LTR. The HIV-1 tat
system does not work well in murine cells because tat
transactivation requires species-specific cell factors (Bien-
iasz et al., 1998). The tat-based cell fusion assay is also
subject to nonspecific activation or repression (Barbeau et
al., 1997; Berube et al., 1996; Klebanoff et al., 1997).
Cell fusion assays have also been based on expression of
T7 RNA polymerase in one cell and an indicator gene
driven by the T7 promoter in another cell (Barbeau et al.,
1998; Nussbaum et al., 1994). Usually, this system
involves the use of vaccinia vectors to achieve high levels
of T7 polymerase in the cytosol and high levels of
cytosolic DNA bearing the T7 DNA promoter-driven
indicator gene. While extremely sensitive, such systems
require safety precautions appropriate for work with
vaccinia virus and are restricted to cells that vaccinia
can infect.
To avoid these complications, we turned to another
potent transcriptional activation system based on a bacte-
rial tetracycline (tet)-regulated promoter adapted for use in
mammalian cells (Gossen and Bujard, 1992). Transcrip-
tion from the tet operator can be strongly induced or
strongly inhibited by a tetracycline transactivator protein
in a tetracycline-regulatable fashion. This system has been
widely used to control gene expression in single cell
types. We adapted it to detect cell fusion by putting the
transactivator in one cell and the transactivator-controlled
reporter gene in another cell. Fusion between cells medi-
ated by several different virus envelope and receptor
genes tested led to strong induction of the indicator gene.
Using this system, we found that the cell fusion compe-
tence of His8 mutants of ecotropic MLV envelope paral-
lels their competence for virus entry, and that virus-
mediated cell fusion can be extensive despite being
limited mainly to fusion between pairs of cells. It may
be useful to consider giant-cell syncytium formation as a
progressive form of cell fusion that escapes normal, self-
limiting processes.Results
Development of the cell–cell fusion assay based on Tet-Off
gene expression system
Tetracycline transcriptional transactivation systems are
commonly used for analysis of gene expression, with the
transcriptional transactivator and reporter gene introduced
into the same cell (Baron and Bujard, 2000). We adaptedit to detect cell fusion as illustrated in Fig. 1. One cell line
was engineered to express a fusogenic form of the MLV
envelope (Rein et al., 1994) and the tetracycline-controlled
transactivator (tTA), a chimeric protein composed of the
N-terminal 207 amino acids of the DNA-binding Tet
repressor protein (TetR) and the C-terminal 127 amino
acids of the Herpes Simplex virus VP16 activation domain
(Gossen et al., 1994). Another cell line was engineered to
express the ecotropic MLV receptor protein mCAT1
(Albritton et al., 1989) and a luciferase reporter under
the control of a tetracycline-response element (TRE)
located just upstream of a minimal CMV promoter
(PminCMV) (Gossen and Bujard, 1992). Constitutive ex-
pression of luciferase is usually low due to the lack of
enhancer elements in PminCMV, but highly inducible when
tTA binds to the TRE. Fusion between the engineered
cells induces transcription of luciferase, detection of which
in a light-emitting assay provides a quantitative measure
of fusion.
In constructing an indicator cell line, it is desirable that
the reporter gene be expressed at low levels before
induction and high levels afterward. Since basal expres-
sion varies in different cell lines (Howe et al., 1995) and
integration sites (Paulus et al., 2000), we first compared
GFP expression in a variety of cell lines transiently
transfected with pTRE2pur-EGFP, a vector encoding en-
hanced green fluorescent protein (EGFP) under the control
of the tTA-inducible promoter (TRE-PminCMV). U2OS cells
and COS7 cells had low background GFP expression with
pTRE2pur-EGFP compared to HEK293, BHK, and XC
cells. U2OS cells were chosen for further work, trans-
fected with a related plasmid (pTRE2pur-Luc) in which
luciferase replaced EGFP, and selected with puromycin.
Individual clones were screened for low background
luciferase activity and high induction following transient
transfection with a tTA expression vector (pTet-Off). One
such clone (U2OS-Luc) was chosen for further work,
transfected with a vector (pECAT-GFP) encoding the
MLV receptor (mCAT1) fused to EGFP and selected with
G418. The mCAT1-GFP fusion gene was used because it
was previously shown to be fully functional as a receptor
(Lee et al., 1999; Lu and Silver, 2000; Masuda et al.,
1999) and it permitted selection of cells expressing high
levels of receptor by flow cytometry for bright GFP
fluorescence. The resultant indicator cell line was desig-
nated U2OS-Luc-CATGFP.
For a fusion partner cell, we chose a previously estab-
lished BHK cell line that stably expresses fusogenic
MLVenv (Kazachkov et al., 2000); these cells were trans-
fected with pTet-Offpur and selected with puromycin,
yielding a cell line designated BHKenv-tTA. Co-culture of
BHKenv-tTA cells with U2OS-Luc-CATGFP indicator cells
led to cell fusion and induction of luciferase to levels 100–
1000-fold greater than in controls in which the MLVenv or
tTA gene was absent (Fig. 2A). As expected, induction of
luciferase was completely suppressed by treatment with 1–5
Fig. 1. Principle of the fusion assay. BHK cells stably expressing MLVenv and a tetracycline-controlled transactivator (tTA) are mixed with U2OS cells stably
expressing the MLV receptor mCAT1 and a luciferase reporter gene under the control of tetracycline-response element (TRE)-regulated minimal CMV
promoter (PminCMV). Cell fusion mediated by the interaction between MLV envelope and receptor results in tTA having access to the tetracycline-response
element (TRE), which activates transcription of luciferase.
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binds tTA and prevents its binding to TRE (Gossen and
Bujard, 1992).
Characterization of the quantitative cell–cell fusion assay
We characterized the fusion assay concerning sensitivity
to the number of fusion events, time for induction of
luciferase, and reproducibility. When varying numbers of
U2OS-Luc-CATGFP, cells were co-cultured with 105
BHKenv-tTA cells, the increase in luciferase activity was
proportional to the number of U2OS-Luc-CATGFP cells
from approximately 102 to 105 cells (Fig. 2C) and leveled
off as the ratio of indicator cells to BHKenv-tTA cells
approached 1 (data not shown). Time course studies showed
that the increase in luciferase activity could be detected 2–4
h after co-cultivation and peaked around 16 h (Fig. 2D).
Repetition of the assay in triplicate on different days
indicated high reproducibility (Fig. 2E).
Because miniaturization of the assay would be poten-
tially useful for screening drugs or treatments that modulate
fusion, we investigated a microtiter-well format with 2 
104 indicator and 2  104 BHKenv-tTA cells per well; cellfusion resulted in an approximately 300-fold increase in
luciferase activity and the variability between wells was
small (Fig. 3A).
For other applications, transient transfection of fusion-
inducing genes would be useful. We transiently transfected
MLVenv and/or tTA genes into HEK293 cells and co-
cultured them with U2OS-Luc cells transiently transfected
with the ecotropic MLV receptor. Luciferase activity in-
creased over 100-fold following co-culture. As expected,
MLVenv, tTA, and the ecotropic MLV receptor were all
required for increased luciferase activity (Fig. 3B).
To see if the assay would work with other viral fusion
proteins, we co-cultured indicator cells with HEK293 cells
transiently transfected with the tTA expression vector plus
expression vectors for amphotropic MLV envelope, HIV-1
envelope, or VSV-G (Clontech, Palo Alto, CA). Luciferase
activity increased approximately 300-fold when we trans-
fected amphotropic MLV envelope lacking its cytoplasmic
tail (Fig. 3B). No increase in luciferase activity was
detected when vectors encoding the full-length amphotropic
or ecotropic envelope was used (data not shown). This
shows that the cell-fusion assay—like virus entry—requires
the ‘‘fusion-activated’’ form of MLV envelope with a
Fig. 2. Characterization of the fusion assay. (A) Specificity. U2OS-Luc-CATGFP indicator cells were co-cultured with BHK cells stably expressing MLVenv,
tTA, or MLVenv + tTA and assayed for luciferase activity. (B) Inhibition of the induction of luciferase by tetracycline. BHKenv-tTA and U2OS-Luc-CATGFP
cells were treated with 0, 1, or 5 Ag/ml of tetracycline during co-cultivation. (C) Linearity. Increasing numbers of U2OS-Luc-CATGFP cells, as indicated, were
co-cultured with 105 of BHKenv-tTA cells. (D) Time course. Equal numbers (105) of U2OS-Luc-CATGFP cells and BHKenv-tTA cell were co-cultured at
different times before assaying luciferase activity. (E) Reproducibility. The fusion assay was performed on three different days. Except for D, the luciferase
activity was measured 16 h after co-cultivation. Error bars indicate the standard deviation of triplicate co-cultures.
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ments with HIV-1 envelope, we used a human glioma cell
line (U373-MAGI-CXCR4CEM) engineered to express the
HIV receptors CD4 and CXCR4 (Vodicka et al., 1997). An
approximately 700-fold increase in luciferase activity was
observed when these cells were transiently transfected with
the luciferase reporter and co-cultivated with HEK293 cells
transfected with pTet-Off plus an expression vector for a
CXCR4-using HIV-1 envelope (Fig. 3B). Control experi-
ments in which the HEK293 cells were transfected with
pTet-Off plus a CCR5-using HIV-1 envelope (AD8) did not
result in increased luciferase activity, although the CCR5-
using envelope-transfected HEK293 cells did fuse with a
CEM.NKR-CCR5-Luc indicator cell line bearing CD4 and
CCR5 (Spenlehauer et al., 2001; Trkola et al., 1999),
showing that the cell fusion assay requires the correct co-
receptor in the case of HIV-1. Luciferase activity increased
approximately 100-fold when pVSV-G was used as the
fusogenic envelope. Since VSV-G fusion is enhanced by
low pH, we treated co-cultured cells briefly with pH5.5
medium; this massively increased syncytium formation but
did not increase luciferase activity (Fig. 3C). In contrast tothe results with ecotropic MLV, the mCAT1 receptor was
unnecessary for fusion mediated by VSV-G (Fig. 3C) or
amphotropic MLV env (not shown). This is expected
because functional receptors for VSV-G and amphotropic
MLV, but not ecotropic MLV, are expressed on human
cells.
Complementation of MLV envelope histidine 8
mutant-mediated cell fusion by soluble receptor-binding
domain (RBD)
Histidine at position 8 in the ecotropic MLV envelope is
not close to the receptor-binding domain in the crystal
structure of MLV envelope (Fass et al., 1997), and viruses
in which histidine 8 is deleted or replaced with arginine or
alanine bind receptor normally but are not infectious (Bae
et al., 1997). Interestingly, the block to virus infection with
these mutants can be reversed by incubating cells with a
soluble form of the amino-terminus of the mature envelope,
which contains the receptor-binding domain (RBD) (Bar-
nett and Cunningham, 2001; Barnett et al., 2001). Co-
culture of U2OS indicator cells with HEK293 cells trans-
Fig. 3. (A) Microtiter plate format. U2OS-Luc-CATGFP cells were co-cultured with BHKenv-tTA cells (or BHKenv cells as a negative control) at 104 cells of
each type per well in 96-well microtiter plates. Error bars indicate the standard deviation of nine wells. (B) Transient transfection. HEK HEK293 cells (1.5 
105) transiently transfected with pTet-Off and an ecotropic MLVenv expression vector (pCEETR), an amphotropic MLVenv expression vector (pCAETR) or a
HIV env expression vector (pdl1443), or no envelope (right side of each pair) were co-cultured with an equal number of indicator cells U2OS-Luc-CATGFP
(for ecotropic and amphotropic MLV) or U373-MAGI-CXCR4CEM transfected with pTRE2pur-luc (for HIV). (C) Fusion mediated by VSV-G. HEK293 cells
co-transfected with pTet-Off and pVSV-G were co-cultured with U2OS-Luc cells (filled bars) or U2OS-Luc-CATGFP cells (hatched bars), with or without
treatment with pH5.5 medium for 1 min after the co-cultured cells had attached to the plate. Nontransfected HEK293 cells were co-cultured with the indicator
cells as a negative control. Error bars indicate the standard deviation of triplicate co-cultures.
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envelope showed no increase in luciferase activity, but
addition of approximately 4 nM RBD peptide resulted in
a 50-fold increase in luciferase activity (Fig. 4). This shows
that the cell fusion competence of His8 mutants of eco-
tropic MLV envelope parallels their competence for virus
entry. The same concentration of RBD mildly inhibited the
fusion activity of cells expressing wild-type ecotropic
envelope, consistent with competition between solubleFig. 4. HEK293 cells (2  105) transfected (or not) with pTet-Off (tTA) and the
histidine 8 replaced with alanine (H8A) or arginine (H8R) were cultured overnigh
indicated concentration of RBD and assayed for luciferase activity the next mornRBD and cell-membrane expressed envelope for receptor
binding sites.
Significant fusion without obvious syncytium formation
Although the cytoplasmic tail-truncated version of MLV
envelope induces syncytia in some cell types, we did not
observe syncytia above background levels in U2OS-Luc-
CATGFP cells cultured with cells expressing fusogenicMo-MLV envelope expression vector pCEETR with wild-type sequence or
t with an equal number of U2OS-Luc-CATGFP cells in the presence of the
ing. Mean of duplicate assays is shown; range was <10% of mean.
Fig. 5. HEK293 cells transfected with the ecotropic MLVenv expression vector pCEETR (A, C) or not transfected (B) were co-cultured overnight with U2OS-
Luc-CATGFP cells (A, B) or XC cells (C). Numerous syncytia are seen in C but not in A or B.
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dred-fold induction of luciferase activity. We considered this
surprising because induction of luciferase must involve
transfer of tTA from envelope-expressing cells to indicatorFig. 6. U2OS-Luc-CATGFP cells were cultured in the presence of approximately
vectors for mitochondrially targeted DsRed (pDsRed-Mito) plus ecotropic MLV e
green fluorescence images from the same field shown in A or a different field (
DsRed-Mito alone are labeled c and m, respectively, in panel A. (D) DIC im
Fluorescence overlay of the same field shown in D. (F) Background syncytium icells. To look more carefully for evidence of cell fusion, we
labeled the MLV-env-expressing HEK293 cells by co-trans-
fecting an expression vector for a mitochondrially targeted
version of the DsRed fluorescent protein (Ou and Silver,5 nM RBD with HEK293 cells that had been transfected with expression
nvelope bearing the H8A mutation. (A) DIC image. (B) Overlay of red and
C). Fused cells indicated with arrows. Cells expressing CATGFP alone or
age of background U2OS-Luc-CATGFP syncytium in same culture. (E)
n pure culture of U2OS-Luc-CATGFP cells.
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CATGFP indicator cells, in which the GFP-labeled MLV
receptor is located mainly on the plasma membrane. Con-
focal microscopy revealed the presence of binucleate cells
with red fluorescent mitochondria and green fluorescent
plasma membrane, indicating cell fusion, when wild-type
envelope was expressed (not shown), or when H8A enve-
lope was expressed in the presence of RBD (Figs. 6A–C).
While slightly larger than cells containing single fluorescent
labels, the doubly labeled cells were not identifiable as
syncytia when observed with transmitted light (Fig. 6A).
Thus, cell fusion does occur in cultures showing induction
of luciferase, but it can be subtle and not proceed to
formation of multinucleate giant cells of the type seen in
co-cultures with highly fusogenic XC cells (Fig. 5C). U2OS
cultures—like many other cell lines—also contain sponta-
neous multinucleate giant cells, identifiable as syncytia
without red mitochondria in our assay (Figs. 6D–F); such
cells complicate attempts to quantify virus-mediated cell
fusion by counting syncytia.Discussion
The quantitative cell fusion assay described here has
several advantages compared to existing cell fusion assays.
The transcriptional activation is based on a well-character-
ized, highly controlled, commercially available expression
vector system. Because it avoids the use of virus vectors, it
is safer and more convenient than assays that require
vaccinia or other viruses. Unlike transactivation mediated
by the HIV tat protein, which does not work well in cells
from certain species due to the need for species-specific
cellular co-factors (Bieniasz et al., 1998), the tetracycline
transcriptional transactivator is not species-restricted. While
we found that the tet-transactivator system did not work
well in some cell types due to a high background of
luciferase expression in the absence of tTA, newer versions
of the luc indicator plasmid with tighter regulation (pTRE-
tight-Luc, Clontech) have been developed that may miti-
gate this problem (http://www.bdbiosciences.com/clontech/
products/literature/pdf/brochures/Tet-On_Tet-Off.pdf).
The assay we describe easily detected fusion with the
four virus envelopes tested: ecotropic MLV (which uses the
mCAT1 receptor), amphotropic MLV (which uses Pit-2),
VSV, and HIV-1. Obvious modifications should allow the
assay to be used with other viruses or fusogenic cell
proteins. The assay is sensitive enough to work in microtiter
format and following transient transfection of fusion genes;
hence, it may be useful to screen agents that inhibit fusion,
or to search libraries for genes that promote fusion. Numer-
ous controls in our experiments showed that transfer of tTA
across cell types is dependent on expression of fusion-
competent envelope and receptor genes.
The assay might also be useful to detect cell fusion
occurring in vivo. Recent studies show that stem celldifferentiation may result from fusion between stem cells
and differentiated cells of the host (Terada et al., 2002; Ying
et al., 2002). Transgenic mouse strains have been created
that carry tTA-activated GFP and lacZ indicator genes
(Krestel et al., 2001), while other strains carry tTA trans-
genes (Kistner et al., 1996). If the background of GFP and
lacZ is low enough, it might be possible to detect rare fusion
events between stem cells from tTA-expressing strains and
host cells in tTA-controlled reporter mice by virtue of
enhanced GFP or lacZ in individual fused cells. Along the
same lines, the assay might be used to study agents that
promote cell fusion in such mice, which could be useful for
stem cell therapy.
The main advantage of the assay is that it provides a
simple, objective, quantitative measure of envelope-mediat-
ed cell fusion. In the case of MLV, most (but not all; see
Yang and Compans, 1997) previous assays have relied on
light-microscopic quantitation of syncytium formation,
which is time-consuming, limited to certain cell types,
affected by envelope sequence in ways that do not correlate
with viral infectivity, and complicated by background syn-
cytia and subjectivity in selecting which fields to count. We
found poor correlation between syncytia detected by routine
light microscopy and increased luciferase activity in the cell
fusion assay. This is most likely because syncytia too small
to be detected by routine microscopy were responsible for
enhanced luciferase production in some cell combinations.
While we cannot rule out ‘‘kiss and run’’ transient cell
fusion (Valtorta et al., 2001) or transfer of envelope-coated
microvesicles (Schartz et al., 2002) containing tTA as a
cause of transcriptional transactivation, such events would
likely transfer less tTA and therefore be much less potent in
inducing luciferase than full cell fusion. They would,
however, be consistent with luciferase induction in the
absence of syncytia. Limitation of cell fusion to pairs of
cells as we observed could have many causes, including low
levels of envelope or receptor on the cell surface, reduction
in concentration of fusion proteins on the cell surface after
fusion takes place, or other post-fusion membrane changes
that inhibit subsequent fusion events. We favor the second
hypothesis because envelope and receptor molecules are
known to interact intracellularly when expressed in the same
cell, altering post-translational modification and trafficking
(Kim and Cunningham, 1993; Wang et al., 1996). Post-
fusion intracellular interaction leading to down-regulation of
envelope or receptor could provide a natural mechanism to
limit subsequent fusion. The availability of functional,
fluorescent-protein-labeled MLV envelope (Kayman et al.,
1999), and receptor proteins in living cells may allow new
approaches to visualizing these proteins during and after cell
fusion in cells in which fusion is limited or progressive.
Restricting cell fusion to pairs of cells would likely promote
the viability of heterokaryons and could have practical
applications in stem cell therapy in view of the reports that
cell fusion is responsible for some forms of stem cell
transdifferentiation.
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Plamids
pTRE2pur-EGFP was constructed by inserting the EGFP
gene, cut from pEGFP-N1 (Clontech) with BamHI/NotI,
into pTRE2pur (Clontech) cut with the same enzymes.
pECAT-GFP was made by inserting mCAT1-GFP, cut from
pSINrep19CAT1GFP (Kazachkov et al., 2000) with BamHI/
NotI, into pEGFP-N1 cut with BglII/NotI. To construct pTet-
Offpur, the neomycin gene in pTet-Off (Clontech) was
excised with XhoI and replaced with the puromycin gene
cut from pTRE2pur with the same restriction enzyme. Both
pTet-Offpur and pTet-Off encode the tTA. Vectors for
expressing ecotropic and amphotropic MLV envelopes with
full-length or truncated cytoplasmic tails (pCEE, pCEETR,
pCAE, and pCAETR) were kind gifts from Jack Ragheb
(Ragheb and Anderson, 1994). Additional vectors encoding
Mo-MLV envelope were made by replacing GFP in pEGFP
with segments of Mo-MLV envelope made by PCR; these
vectors gave equivalent results as pCEE and pCEETR.
Mutations at amino acid 8 in Mo-MLV were made by
PCR mutagenesis and confirmed by sequencing. The
VSV-G expression plasmid (pVSV-G) was from Clontech.
RBD expression and purification
RBD-His was prepared generally following a previously
published method (Davey et al., 1997). A cDNA encoding
the N-terminal 268 residues of Moloney Murine Leukemia
virus envelope (receptor binding domain, RBD) with a C-
terminal protease cleavage site and His6 tag was generated
by polymerase chain reaction using RBD-forward primer
5VAGGTACTAGTACTGACATGGCGCGTTCAAC3V,
RBD-His reverse primer 5VGGTACTCGACTAGTGTGAT-
GGTGATGGTGATGGCCCTGAAAATACAGGTTTTC-
GGTCGTCGGGATATCGTAATCTATTGGGACGCGGG-
GTCCTA3V, and a shorter version of the reverse primer
5VGGTACTCGACTAGTGTGATGGTGATGGT3V. The
PCR product was digested by SpeI and inserted into SpeI
site of pFastBac1 vector (Invitrogen, Carlsbad, CA). One
nanogram of pFastBac1-RBD-His6 was transformed into
DH10BAC competent cells (Invitrogen) to produce recom-
binant bacmid DNA. Bacmid DNAwas transfected into Sf9
cells to produce recombinant virus, which was amplified by
infection of Sf9 cells. For production of RBD, Sf9 cells were
grown to 2  106 per milliliter in suspension at 27 jC with
shaking and infected with recombinant baculovirus at a
multiplicity of infection of 5. Two days later, supernatants
were collected by centrifugation for 5 min at 500  g,
incubated for 1 h in a cold room with ProBond resin
(Invitrogen, 20 ml of resin per liter of medium). The resin
was loaded on a column by gravity, and washed with 10
column volumes each of 20 mM sodium phosphate–500
mM NaCl (pH 6.0) and 50 mM imidazole–20 mM sodium
phosphate–500 mM NaCl (pH 6.0). The bound protein waseluted with 500 mM imidazole–20 mM sodium phosphate–
500 mMNaCl (pH 6.0) and dialyzed against 500 mMNaCl–
20 mM HEPES (pH 7.4) for 2 days. Protein concentration
(205 Ag/ml,f7 AM) was determined with BCA kit (Pierce).
Flow cytometry indicated that the purified RBD (detected
with antibody to the His tag) bound to cells expressing
mCAT1 (XC, NIH3T3, HEK293-CATGFP) but not to con-
trol cells (HEK293, MLV-infected NIH3T3 cells).
Transfection and selection
Cells were grown in Dulbecco’s modified Eagle’s medi-
um supplemented with 10% fetal bovine serum, 200 U of
penicillin per milliliter, 200 Ag of streptomycin sulfate per
milliliter, and 2 AM L-glutamine (DMEM+) at 37 jC in a 5%
CO2 incubator. For transfection, 10
6 cells were seeded per
well of a six-well plate, cultured at 37 jC overnight, and
transfected by replacing the medium with 0.5 ml of serum-
free Opti-MEM medium (Gibco, Frederick, MD) to which
2–4 Ag DNA and 4–8 Al LipofectAMINE2000 (Invitrogen)
were mixed per the manufacturer’s instructions. After 3–6
h at 37 jC, the medium was replaced with DMEM+medium.
To select stable cell lines, transfected cells were split 24
h after transfection and incubated with DMEM+, containing
1 mg/ml G418 or 4 Ag/ml puromycin. Medium with neo-
mycin or puromycin was changed every 72 h for 2 weeks.
Cells expressing high levels of mCAT1-GFP were selected
by flow cytometry for high GFP fluorescence with a FAC-
Star Plus cell sorter (BD, Franklin Lakes, NJ).
Cell fusion assay
Stably or transiently transfected target and indicator cells
were trypsinized, mixed at different ratios, plated in replicate
wells, and incubated at 37 jC in a 5% CO2 incubator for 16
h (or other times as indicated). Luciferase activity was
quantified with the Luciferase Assay System (Promega,
Madison, WI). Briefly, culture medium was removed and
cells were lysed with 0.2–0.5 ml of passive lysis buffer in
which they were frozen on dry ice for 5 min, thawed in a 37
jC water bath, and vortexed. After spinning in a micro-
centrifuge at 12000 rpm for 5 min to remove cell debris, 100
Al of luciferase assay regent was injected into 20 Al of
supernatant and the luminosity was measured with an Opto-
comp II luminometer (MGM Instruments, Hamden, CT).
Confocal microscopy
Cells were grown in LabTek Chambered Coverglass
devices and examined with a Leica SP2-AOBS confocal
microscope with a 63 oil immersion NA 1.32 objective.
GFP andDsRedwere excitedwith argon and krypton lasers at
488 and 568 nm, respectively; detector slits were adjusted to
minimize cross-talk between the channels. DIC images were
collected simultaneously using a transmitted light detector.
Images were processed using Leica TCS-NT/SP software.
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